One study found that immune-mediated inflammatory disease patients receiving anti-TNF-α treatment had elevated rates of mycobacterial disease and that NTM disease was associated with rheumatoid arthritis (RA) [36]. This evidence concerns the gene TNF and rheumatoid arthritis.